The Indiana Clinical and Translational Sciences Institute (CTSI) and Indiana University offer a variety of funding opportunities that are open to IUSM researchers. These include funding for basic research and clinical trials as well as specialized opportunities for equipment. 

Technology Enhancement Awards (TEA)

In partnership with the SPARK program at Stanford, Spark Indy a new funding and mentoring mechanism is underway to support enhancement  of early stage technologies to commercialization. In partnership with Indiana CTSI and Indiana University School of Medicine through the office of the Associate Dean for Entrepreneurship and its Industry Collaboration Portal (ICP), and the Indiana Center for Biomedical Innovation (ICBI) at IUHealth theTechnology Enhancement Awards is geared to fill the critical gap between innovation and commercialization. Submission due date is Friday, July 8th, 2016 at 5:00 PM – Online application Technology Enhancement Award (TEA)

Indiana Drug Discovery Alliance (IDDA)

The Indiana Drug Discovery Alliance (IDDA) aims to promote and support promising early-stage drug discovery research in Indiana. IDDA facilitates collaborative translational research and partnerships through identification of complementary expertise and support for team building across diverse disciplines. Small grants are available to support new collaborations and/or the use of core facilities that enable the translation of fundamental discoveries related to drug discovery. For more information about IDDA, email ictsi@iu.edu

Strategic Pharma-Academic Research Consortium (SPARC) Awards Program

The Midwest Strategic Pharma-Academic Research Consortium (SPARC) is a group of universities and pharmaceutical companies dedicated to addressing research challenges facing the pharmaceutical industry. The research is in the noncompetitive space of mutual interest that addresses scientific and technological research challenges confronting the pharmaceutical industry. SPARC’s founding members are Indiana University, Northwestern University, Ohio State University, Washington University in St. Louis, Eli Lilly and Company, and Takeda Pharmaceuticals.

Indiana Clinical and Translational Sciences Institute

Indiana University